SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-20-079774
Filing Date
2020-07-01
Accepted
2020-07-01 17:00:47
Documents
6
Period of Report
2020-08-12
Effectiveness Date
2020-07-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2023902-1_def14a.htm DEF 14A 321424
2 GRAPHIC tm2023902-1_def14aimg001.jpg GRAPHIC 2869
3 GRAPHIC tm2023902-1_def14aimg002.jpg GRAPHIC 4461
4 GRAPHIC tm2023902-1_def14aimg003.jpg GRAPHIC 13544
5 GRAPHIC tm2023902-1_def14aimg004.jpg GRAPHIC 352715
6 GRAPHIC tm2023902-1_def14aimg005.jpg GRAPHIC 205913
  Complete submission text file 0001104659-20-079774.txt   1121750
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-35963 | Film No.: 201005934
SIC: 2834 Pharmaceutical Preparations